Author： O'Sullivan Amy K.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.29, Iss.8, 2011-08, pp. : 693-704
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Soaring costs of cardiovascular disease in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 621, 2011-01 ,pp. :
Access to resources
Recommend
Adverse events cost US Medicare, hospitals dearly
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 518, 2006-01 ,pp. :
Ramipril cost effective in patients at high risk for cardiovascular events
Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. :
Ramipril cost effective in patients at high risk for cardiovascular events
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 464, 2004-01 ,pp. :
Cost Effectiveness of Pramipexole in Parkinson's Disease in the US
By Hoerger T.J.
PharmacoEconomics, Vol. 14, Iss. 5, 1998-11 ,pp. :